Efficacy and safety of cis-trans-1,4-cyclohaxanediol gel in the case of adult patients with rosacea, seborrheic dermatitis and facial dermatitis

Postepy Dermatologii I Alergologii

Volumn 22, Issue 6, 2005, Pages 271-277

  Silny, Wojciech ^a   Chomczyński, Piotr ^b   Czarnecka Operacz, Magdalena ^a   Danczak Pazdrowska, Aleksandra ^a   Silny, Paweł ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MRC   (United States)

Author keywords

1,4 Cyclohexanediol; Face dermatitis; Perioral dermatitis; Rosacea; Skin inflammation; Soborrheic dermatitis

Indexed keywords

ALICYCLIC HYDROXY COMPOUND; ANTIHISTAMINIC AGENT; CYCLOHEXANE 1,4 DIOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CONTACT DERMATITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; FACE DISORDER; FEMALE; HUMAN; MALE; PAPULE; PERIORAL DERMATITIS; PRURITUS; PUSTULE; ROSACEA; SCORING SYSTEM; SEBORRHEIC DERMATITIS; STATISTICAL SIGNIFICANCE; TELANGIECTASIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 30844448977     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chren MM, Lasek RJ, Quinn LM, et al.: Skindex, a quality-of-life measure for subjects with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.
2. Abramova L, Yeung J, Chren MM: Rosacea quality of life index (RosaQol). J Am Dermatol 2004; 5 (suppl. 3): pp. P12.
3. Chomczynski P: Method of treating rosacea, US Patent 6,723,755, 2004, other US and international patent pending.
4. Bobrzański B, Tołłoczko S: Chemia organiczna. PWN, Warszawa 1997.
5. Mills GA, Walker V. Urinary excretion of cyclohexanediol, a metabolite of solvent cycolhexane, by infants in a special care unit. Clin Chem 1990; 36: 870-4.
6. Perlico A, Cassinelli C, Brugnone F, et al.: Biological monitoring of occupational exposure to cyclohexane by urinary 1,2- and 1,4-cyclohexanediol determination. Int Arch Occup Environ Health 1999; 72: 115-20.
7. Imada A, Hirai S: Cefotiam hexetil. Int J Antimicrob Agents 1995; 5: 85-9.
8. Mráz J, Gálová E, Nohová H, et al.: 1,2- and 1,4-cyclohexanediol: major urinary metabolitem and biomarkers of exposure to cyclohexane, cyclohexanone, and cyclohexanol in humans. Int Arch Occup Environ Health 1998; 71: 560-5.
9. Bromm B, Scharein E, Darsow U, et al.: Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neuroscience Letters 1995; 187: 157-60.
10. Gelal A, Jacob III P, Yu L, et al.: Disposition kinetics and effects of menthol. Clin Pharm Therap 1999; 66: 128-35.